Connection

Franco Locatelli to Molecular Targeted Therapy

Back to Details
This is a "connection" page, showing publications Franco Locatelli has written about Molecular Targeted Therapy.
Franco Locatelli
Connection Strength
0.021
Molecular Targeted Therapy
  1. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. Clin Cancer Res. 2017 Aug 01; 23(15):4462-4472.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.